Rosenberg N L
Department of Tumor Biology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston 77030.
Mol Cell Biochem. 1987 Aug;76(2):113-21. doi: 10.1007/BF00223476.
The studies reported here demonstrate that ATP may be used in lieu of EDTA to inhibit nuclease digestion of DNA and chromatin. Because ATP is a milder chelator than EDTA and is a biochemical common to the cellular microenvironment in vivo, critical studies of cellular processes that require native structure to be maintained are more feasible without the presence of strong chelators. During the digestion of chromatin into its components by nuclease treatment, ATP assures the retention of nucleoprotein compaction, particularly for large to intermediate-sized oligosomes (2400bp-1000bp in length). ATP used at a concentration of 3.3 mM appears to be somewhat better than EDTA, 1.0 mM, for minimizing degradation of nuclease-treated chromatin. However, termination of nuclease digestion of chromatin and minimization of further degradation by the addition of ATP to a concentration of 1.0 mM was almost equivalent to the addition of EDTA to a concentration of 1.0 mM. Slightly more degradation was observed for the latter condition. In addition, ATP can be used to inhibit endogenous nuclease activity when specific restriction enzymes are needed. Standard low ionic strength DNP, deoxyribonucleoprotein, and DNA electrophoresis of proteinized and deproteinized chromatin oligomers, respectively, indicated that ATP effectively inhibits staphylococcal nuclease. Low ionic strength nucleoprotein electrophoresis to resolve staphylococcal nuclease-digested chromatin indicates that as little as 10(-4) M EDTA can promote structural unfolding resulting in changes in apparent mobilities for chromatin oligomers 250 and 600 bp in length. Comparative digestion of chromatin with staphylococcal nuclease followed by reaction termination by ATP or EDTA showed that this observation was not merely the result of degradation due to inefficiency of ATP enzyme inhibition.
此处报道的研究表明,ATP可用于替代EDTA来抑制DNA和染色质的核酸酶消化。由于ATP是一种比EDTA更温和的螯合剂,并且是体内细胞微环境中的一种生化物质,因此在没有强螯合剂存在的情况下,对需要维持天然结构的细胞过程进行关键研究更可行。在用核酸酶处理将染色质消化成其组成成分的过程中,ATP可确保核蛋白紧密结构的保留,特别是对于大到中等大小的寡核小体(长度为2400bp - 1000bp)。浓度为3.3 mM的ATP在使核酸酶处理的染色质降解最小化方面似乎比1.0 mM的EDTA稍好。然而,将ATP添加到1.0 mM浓度以终止染色质的核酸酶消化并使进一步降解最小化,几乎等同于添加到1.0 mM浓度的EDTA。在后一种情况下观察到的降解略多一些。此外,当需要特定限制酶时,ATP可用于抑制内源性核酸酶活性。分别对蛋白质化和去蛋白质化的染色质寡聚体进行标准低离子强度的DNP(脱氧核糖核蛋白)和DNA电泳,表明ATP能有效抑制葡萄球菌核酸酶。通过低离子强度核蛋白电泳来解析葡萄球菌核酸酶消化的染色质表明,低至10^(-4) M的EDTA可促进结构展开,导致长度为250和600 bp的染色质寡聚体的表观迁移率发生变化。用。用葡萄球菌核酸酶对染色质进行比较消化,然后用ATP或EDTA终止反应,结果表明这一观察结果不仅仅是由于ATP酶抑制效率低下导致降解的结果。